Elon Musks New $1 Quadrillion Opportunity

Dear , The analysts at JP Morgan initiated coverage on Nikola Motors (NKLA) the other day… They wrote the stock was fully valued, giving it a neutral rating and a price target of $45. Nikola that day opened at $64 per share… and ended up closing at $70.  The stock gained more than 6.2% despite the lackluster report from the analysts… Make no mistake about it… Some analysts are completely ignored… While others move the needle… How do you know which ones they are? Simple, for me.  I just follow the smart money.  Inovio (INO) got upgraded by Maxim yesterday, as they raised its target from $18 to $24.  The smart money started to jump into the options… 13 minutes after the market opened… A trader came in and bought 540 INO Jun20 26th $16.0 Calls  Paying $1.10 Per Contract  A Total of $59K In Premium In just a matter of hours… Those calls were worth about $5… In other words, the $59K bet… Turned into a profit of $210K. You see, on average there are 31k call contracts of INO traded per day… However, more than 220K contracts trade on Tuesday… A dead giveaway the Maxim report had weight…   If you want to make money in the market… You have to know where the largest players are moving the pieces… That's why I wrote Dollar Option Trader.  Not only does it explain how order flow works.  But it's also a blueprint for tracking down smart money options activity. You'll learn their moves by reading the case studies.   As well, as my number #1 strategy to profit off them. Download your copy now. Kyle Dennis RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 Click Here to stop receiving emails from kyle@biotechbreakouts.com Unsubscribe from all RagingBull emails DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website,application or other service ("Services"), please review our full disclaimer located at https://ragingbull.com/disclaimer. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT beconstrued as a securities-related offer or solicitation, or be relied upon as personalizedinvestment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securitiesregulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, Ragingbull.com, LLC, its owners, and itsemployees may purchase, sell, or hold long or short positions in securities of the companies mentioned inthis communication. If you have a current active subscription with Biotech Breakouts you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com.